An 82-year-old woman with worsening hypertension: Review of renal artery stenosis

JAMA

Volumn 300, Issue 17, 2008, Pages 2036-2044

  Rosenfield, Kenneth ^a,b   Jaff, Michael R ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; ATENOLOL PLUS CHLORTALIDONE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; FELODIPINE; FLUINDOSTATIN; METHYLDOPA; MULTIVITAMIN; NABUMETONE; NIFEDIPINE; OMEPRAZOLE; RAMIPRIL; VITAMIN D; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANAMNESIS; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE REGULATION; CASE REPORT; CLINICAL EXAMINATION; COUGHING; DISEASE COURSE; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; EVENING DOSAGE; FEMALE; HEART RATE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION TEST; LEG EDEMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVASCULARIZATION; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; GLOMERULUS FILTRATION RATE; PATHOPHYSIOLOGY; REVIEW; VASCULAR SURGERY;

AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; RENAL ARTERY OBSTRUCTION; VASCULAR SURGICAL PROCEDURES;

EID: 55549137398     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.13.jrr80009     Document Type: Article

References (54)

1. Simon N, Franklin SS, Bleifer KH, Maxwell MH. Clinical characteristics of renovascular hypertension. JAMA. 1972;220(9):1209-1218.
2. Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002;77(4):309-316.
3. Edwards MS, Craven TE, Burke GL, Dean RH, Hansen KJ. Renovascular disease and the risk of adverse coronary events in the elderly. Arch Intern Med. 2005;165(2):207-213.
4. Conlon PJ, Athirakul K, Kovalik E, et al. Survival in renal vascular disease. J Am Soc Nephrol. 1998;9(2):252-256.
5. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344(6):431-442.
6. White CJ, Jaff MR, Haskal ZJ, et al; American Heart Association Council on Kidney in Cardiovascular Disease. Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease. Circulation. 2006;114(17):1892-1895.
7. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252.
8. Olin JW, Piedmonte MR, Young JR, DeAnna S, Grubb M, Childs MB. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med. 1995;122(11):833-838.
9. Gedroyc WMW, Neerhut P, Negus R, et al. Magnetic resonance angiography of renal artery stenosis. Clin Radiol. 1995;50(7):436-439.
10. Vasbinder GBC, Nelemans PJ, Kessels AGH, et al; Renal Artery Diagnostic Imaging Study in Hypertension (RADISH) Study Group. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141(9):674-682.
11. Tan KT, van Beek EJ, Brown PW, van Delden OM, Tijssen J, Ramsay LE. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol. 2002;57(7):617-624.
12. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol. 2007;188(2):586-592.
13. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344(6):410-417.
14. Bolduc JP, Oliva V, Therasse E, et al. Diagnosis and treatment of renovascular hypertension: a cost-benefit analysis. AJR Am J Roentgenol. 2005;184(3):931-937.
15. Greco BA, Breyer JA. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy? Semin Nephrol. 1996;16(1):2-11.
16. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE Jr. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg. 1994;19(2):250-258.
17. Scoble JE, Maher ER, Hamilton G, Dick R, Sweny P, Moorhead JF. Atherosclerotic renovascular disease causing renal impairment - a case for treatment. Clin Nephrol. 1989;31(3):119-122.
18. Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med. 2006;145(12):901-912.
19. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, Abdominal Aortic): a Collaborative Report From the American Association of Vascular Surgery/Society for Vascular Surgery, Society of Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine and Biology, and the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. http://www.acc.org/clinical/guidelines/pad/index.pdf. Accessed October 7, 2008.
20. Davis BA, Crooke JE, Vestal RE, Oates JA. Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N Engl J Med. 1979;301(23):1273-1276.
21. Hollenberg NK. Medical therapy for renovascular hypertension: a review. Am J Hypertens. 1988;1(4 pt 2):338S-343S.
22. Textor SC. ACE inhibitors in renovascular hypertension. Cardiovasc Drugs Ther. 1990;4(1):229-235.
23. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensinconverting enzyme inhibitor or calcium channel blockers vs diuretic: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial. JAMA. 2002;288(23):2981-2997.
24. Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006;152(1):59-66.
25. Cambria RP, Brewster DC, L'Italien GJ, et al. The durability of different reconstructive techniques for atherosclerotic renal artery disease. J Vasc Surg. 1994;20(1):76-87.
26. Hansen KJ, Cherr GS, Craven TE, et al. Management of ischemic nephropathy: dialysis-free survival after surgical repair. J Vasc Surg. 2000;32(3):472-482.
27. Sos TA, Pickering TG, Sniderman K, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med. 1983;309(5):274-279.
28. Canzanello VJ, Millan VG, Spiegel JE, Ponce PS, Kopelman RI, Madias NE. Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: results in 100 patients. Hypertension. 1989;13(2):163-172.
29. White CJ, Ramee SR, Collins TJ, Jenkins JS, Escobar A, Shaw D. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol. 1997;30(6):1445-1450.
30. Rocha-Singh K, Jaff MR, Rosenfield K; ASPIRE-2 Trial Investigators. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 Study. J Am Coll Cardiol. 2005;46(5):776-783.
31. Bates MC, Campbell JE, Stone PA, Jaff MR, Broce M, Lavigne PS. Factors affecting long-term survival following renal artery stenting. Catheter Cardiovasc Interv. 2007;69(7):1037-1043.
32. Ivanovic V, McKusick M, Johnson M, et al. Renal artery stent placement: complications at a single tertiary care center. J Vasc Interv Radiol. 2003;14(2 pt 1):217-225.
33. Burket MW, Cooper CJ, Kennedy DJ, et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J. 2000;139(1 pt 1):64-71.
34. Rocha-Singh KJ, Mishkel GJ, Katholi RE, et al. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Catheter Cardiovasc Interv. 1999;47(2):167-172.
35. Rodriguez-Lopez JA, Werner A, Ray LI, et al. Renal artery stenosis treated with stent deployment: indications, technique, and outcome for 108 patients. J Vasc Surg. 1999;29(4):617-624.
36. van de Ven PJG, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomized trial. Lancet. 1999;353(9149):282-286.
37. Rundback JH, Gray RJ, Rozenblit G, et al. Renal artery stent placement for the management of ischemic nephropathy. J Vasc Interv Radiol. 1998;9(3):413-420.
38. Tuttle KR, Chouinard RF, Webber JT, et al. Treatment of atherosclerotic renal artery stenosis with the intravascular stent. Am J Kidney Dis. 1998;32(4):611-622.
39. Blum U, Krumme B, Flugel P, et al. Treatment of ostial renal artery stenoses with vascular endoprosthesis after unsuccessful balloon angioplasty. N Engl J Med. 1997;336(7):459-465.
40. Harden PN, MacLeod MJ, Rodger RSC, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet. 1997;349(9059):1133-1136.
41. Iannone LA, Underwood PL, Nath A, Tannenbaum MA, Ghali MG, Clevenger LD. Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis. Cathet Cardiovasc Diagn. 1996;37(3):243-250.
42. Dorros G, Jaff M, Jain A, Dufek C, Mathiak L. Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol. 1995;75(15):1051-1055.
43. Hennequin LM, Joffre FG, Rousseau HP, et al. Renal artery stent placement: long-term results with the Wallstent endoprosthesis. Radiology. 1994;191(3):713-719.
44. Lim ST, Rosenfield K. Renal artery stent placement: indications and results. Curr Interv Cardiol Rep. 2000;2(2):130-139.
45. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. N Engl J Med. 2000;342(14):1007-1014.
46. Silva JA, Chan AW, White CJ, et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation. 2005;111(3):328-333.
47. Zähringer M, Sapoval M, Pattynama PMT, et al. Sirolimus-eluting versus baremetal low-profile stent for renal artery treatment (GREAT trial): angiographic follow-up after 6 month and clinical outcome up to 2 years. J Endovasc Ther. 2007;14(4):460-468.
48. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg. 2003;38(5):962-968.
49. Cooper CJ, Haller ST, Colyer W, et al. Embolic protection and platelet inhibition during renal artery stenting. Circulation. 2008;117(21):2752-2760.
50. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patters of age-related changes in blood pressure: the Framingham Heart Study. Circulation. 1997;96(1):308-315.
51. Lederman RJ, Medelsohn FO, Santos R, et al. Primary renal artery stenting: characteristics and outcomes after 367 procedures. Am Heart J. 2001;142(2):314-323.
52. Grundy SM, Cleeman JI, Merz CN, et al; Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004;44(3):720-732.
53. Muray S, Martin M, Amoedo M, et al. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis. 2002;39(1):60-66.
54. Rocha-Singh KJ, Mishkel GJ, Katholi RE, et al. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Cath Cardiovasc Intervent. 1999;47(2):167-172.